Lund Stem Cell Center ES/iPS Facility
The human pluripotent stem cell core facility is dedicated to promoting research involving embryonic stem (ES) cells and induced pluripotent stem (iPS) cells within the state recognized Strategic Research Area (SFO) STEM THERAPY, with close collaboration from the SFOs EXODIAB and MULTIPARK.
The ES/iPS platform is a state-of-the-art, modular designed, and fully equipped tissue culture facility with separate cell introduction room, clean room, and access to vector transduction room, all within a shared entrance vestibule. The facility provides access to in-house quality tested culturing medias reagents and protocols. We also provide full-service generation of novel patient derived induced pluripotent stem cell lines. We offer training in advance pluripotent cell culture techniques to new users. As part of the core we also offer expert consultation on latest developments in pluripotent cell research and technologies.
Moreover, the core has also arranged to be able to provide Stem Therapy users with access to the Harvard and WiCell generated human ES lines through an accelerated application process where the PIs use a pre-approved a material transfer agreement application form.